This protocol provides the methodology of vagotomy procedure and tamoxifen injections in a murine model, investigating the pathological role of alpha-synuclein in the gastrointestinal (GI) system. The mouse model includes features of exclusive expression of alpha-synuclein in cholecystokinin (CCK) cells within the gut.
The protocol intricately details the surgical procedure, including a dissection of the vagus node to ensure the mice not only survive but thrive post-surgery. Subsequent tamoxifen injections, utilizing a tamoxifen-inducible promoter, aim to induce the expression of alpha-synuclein.
The significance of this protocol lies in presenting a unified and standardized procedure for both vagotomy and tamoxifen injections. This streamlined approach is crucial for investigating the role of alpha-synuclein in the GI system.